This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


The Clinical Interface of Depression and Dementia

Murray A. Raskind, M.D.

Published: March 1, 1998

Article Abstract

The interface between depression and dementia is complex and has been studied primarily in Alzheimer’s disease. This article discusses several aspects of this intriguing area of clinical research, includingdepressive pseudodementia and the possibility that depression may be a risk factor for the expressionof Alzheimer’s disease in later life and that depression may occur as a prodrome for this mostcommon dementing disorder. In addition, the treatment challenges faced by clinicians when depressioncomplicates the course of Alzheimer’s disease are addressed. It is likely that a combination ofbehavioral treatment and use of antidepressant medication will provide the optimal management ofdepression in Alzheimer’s disease.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 59

Quick Links: Dementia , Neurologic and Neurocognitive


Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...